Foresite Capital Fund IV, L.P.

13F Holdings History for Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 (LYEL)

Symbol: LYEL on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001
Latest Disclosed Ownership: 1.45M shares
Security Ownership: 7.6%

James B. Tananbaum ownership in Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL)

2025-11-14 - James B. Tananbaum has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.45M shares of Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL). This represents 7.6% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
James B. Tananbaum	7.6%		$23.6M	1.45M			$16.24	13G/A	9/30/2025	14 Nov 2025 16:05:18